JENNIFER FURLOW: Open Payments
NPI 1770845968 · CHARLOTTESVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$337 in 18 payments from 12 companies in 2025. Trend: 2023 $533 · 2024 $346 · 2025 $337
Food & beverage: $337
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $74 |
| Vanda Pharmaceuticals Inc. | 2 | $55 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $34 |
| REVANCE THERAPEUTICS, INC. | 1 | $24 |
| Exact Sciences Corporation | 1 | $19 |
| Corium, LLC | 1 | $18 |
| Ardelyx, Inc. | 1 | $17 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
Products named: VRAYLAR, REXULTI, CAPLYTA, HETLIOZ, DAXXIFY, FANAPT, The Cologuard Plus Collection Kit, Azstarys.
Industry payments across VA — which companies pay providers there.
